Plain-English translation of NCT02677064 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study is observational, meaning researchers will follow your medical journey over time rather than testing a new medication. Doctors at Memorial Sloan Kettering want to understand the real-world reasons why some patients with acute leukemia, myelodysplastic syndrome, or myeloproliferative neoplasms don't proceed with allogeneic hematopoietic stem cell transplantation, even when it's medically appropriate and they're eligible.
Stem cell transplantation can be a powerful treatment for certain blood cancers, but many eligible patients never receive it. Researchers want to identify what barriers—whether medical, personal, financial, or logistical—prevent patients from accessing this treatment so that future patients can get better support and information.
You likely qualify if…
You likely don't qualify if…
You will continue your regular cancer care with your doctor while researchers observe and document your medical journey. They will track whether you proceed with a stem cell transplant and, if not, work to understand what prevented it—whether that's related to your health status, availability of a donor, personal preference, side effect concerns, or other factors. The study involves reviewing your medical records and may include conversations with your care team about your treatment decisions.
AI-generated summary from trial data · Aug 5, 2026 · Not medical advice
United States